 | • レポートコード：20QY06-02976 • 出版社/出版日：QYResearch / 2020年6月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、131ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、ヒストンデアセチラーゼ（HDAC）阻害剤のグローバル市場について種類別（ヒドロキサメート、環状ペプチド、脂肪族酸、ベンズアミド）、用途別（がん、中枢神経系障害、その他疾患）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・ヒストンデアセチラーゼ（HDAC）阻害剤市場の概要 ・世界の主要地域別ヒストンデアセチラーゼ（HDAC）阻害剤市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のヒストンデアセチラーゼ（HDAC）阻害剤市場規模2015-2026：種類別（ヒドロキサメート、環状ペプチド、脂肪族酸、ベンズアミド） ・世界のヒストンデアセチラーゼ（HDAC）阻害剤市場規模2015-2026：用途別（がん、中枢神経系障害、その他疾患） ・ヒストンデアセチラーゼ（HDAC）阻害剤の北米市場規模2015-2020 ・ヒストンデアセチラーゼ（HDAC）阻害剤のヨーロッパ市場規模2015-2020 ・ヒストンデアセチラーゼ（HDAC）阻害剤の中国市場規模2015-2020 ・ヒストンデアセチラーゼ（HDAC）阻害剤の日本市場規模2015-2020 ・ヒストンデアセチラーゼ（HDAC）阻害剤の東南アジア市場規模2015-2020 ・ヒストンデアセチラーゼ（HDAC）阻害剤のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Celgene、Celleron Therapeutics、CrystalGenomics、Acetylon Pharmaceuticals、Novartis、Envivo Pharmaceuticals） ・ヒストンデアセチラーゼ（HDAC）阻害剤の製造コスト分析 ・販売チャネル、流通業者、顧客 ・ヒストンデアセチラーゼ（HDAC）阻害剤の市場動向・機会・課題 ・調査の結論 |
Market Analysis and Insights: Global Histone Deacetylase (HDAC) Inhibitor Market
The global Histone Deacetylase (HDAC) Inhibitor market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026.
Global Histone Deacetylase (HDAC) Inhibitor Scope and Market Size
The global Histone Deacetylase (HDAC) Inhibitor market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Histone Deacetylase (HDAC) Inhibitor market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Histone Deacetylase (HDAC) Inhibitor market is segmented into
Hydroxamates
Cyclic Peptides
Aliphatic Acids
Benzamides
Segment by Application, the Histone Deacetylase (HDAC) Inhibitor market is segmented into
Cancer
Central Nervous System Disorders
Other Diseases
The Histone Deacetylase (HDAC) Inhibitor market is analysed and market size information is provided by regions (countries). Segment by Application, the Histone Deacetylase (HDAC) Inhibitor market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Histone Deacetylase (HDAC) Inhibitor Market Share Analysis
Histone Deacetylase (HDAC) Inhibitor market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Histone Deacetylase (HDAC) Inhibitor business, the date to enter into the Histone Deacetylase (HDAC) Inhibitor market, Histone Deacetylase (HDAC) Inhibitor product introduction, recent developments, etc.
The major vendors covered:
Celgene
Celleron Therapeutics
CrystalGenomics
Acetylon Pharmaceuticals
Novartis
Envivo Pharmaceuticals
…
Table of Contents
1 Histone Deacetylase (HDAC) Inhibitor Market Overview
1.1 Histone Deacetylase (HDAC) Inhibitor Product Scope
1.2 Histone Deacetylase (HDAC) Inhibitor Segment by Type
1.2.1 Global Histone Deacetylase (HDAC) Inhibitor Sales by Type (2020-2026)
1.2.2 Hydroxamates
1.2.3 Cyclic Peptides
1.2.4 Aliphatic Acids
1.2.5 Benzamides
1.3 Histone Deacetylase (HDAC) Inhibitor Segment by Application
1.3.1 Global Histone Deacetylase (HDAC) Inhibitor Sales Comparison by Application (2020-2026)
1.3.2 Cancer
1.3.3 Central Nervous System Disorders
1.3.4 Other Diseases
1.4 Histone Deacetylase (HDAC) Inhibitor Market Estimates and Forecasts (2015-2026)
1.4.1 Global Histone Deacetylase (HDAC) Inhibitor Sales Growth Rate (2015-2026)
1.4.2 Global Histone Deacetylase (HDAC) Inhibitor Revenue and Growth Rate (2015-2026)
1.4.3 Global Histone Deacetylase (HDAC) Inhibitor Price Trends (2015-2026)
2 Histone Deacetylase (HDAC) Inhibitor Estimate and Forecast by Region
2.1 Global Histone Deacetylase (HDAC) Inhibitor Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Histone Deacetylase (HDAC) Inhibitor Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Histone Deacetylase (HDAC) Inhibitor Sales Market Share by Region (2015-2020)
2.2.2 Global Histone Deacetylase (HDAC) Inhibitor Revenue Market Share by Region (2015-2020)
2.3 Global Histone Deacetylase (HDAC) Inhibitor Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Histone Deacetylase (HDAC) Inhibitor Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Histone Deacetylase (HDAC) Inhibitor Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Histone Deacetylase (HDAC) Inhibitor Estimates and Projections (2015-2026)
2.4.2 Europe Histone Deacetylase (HDAC) Inhibitor Estimates and Projections (2015-2026)
2.4.3 China Histone Deacetylase (HDAC) Inhibitor Estimates and Projections (2015-2026)
2.4.4 Japan Histone Deacetylase (HDAC) Inhibitor Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Histone Deacetylase (HDAC) Inhibitor Estimates and Projections (2015-2026)
2.4.6 India Histone Deacetylase (HDAC) Inhibitor Estimates and Projections (2015-2026)
3 Global Histone Deacetylase (HDAC) Inhibitor Competition Landscape by Players
3.1 Global Top Histone Deacetylase (HDAC) Inhibitor Players by Sales (2015-2020)
3.2 Global Top Histone Deacetylase (HDAC) Inhibitor Players by Revenue (2015-2020)
3.3 Global Histone Deacetylase (HDAC) Inhibitor Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Histone Deacetylase (HDAC) Inhibitor as of 2019)
3.4 Global Histone Deacetylase (HDAC) Inhibitor Average Price by Company (2015-2020)
3.5 Manufacturers Histone Deacetylase (HDAC) Inhibitor Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Histone Deacetylase (HDAC) Inhibitor Players (Opinion Leaders)
4 Global Histone Deacetylase (HDAC) Inhibitor Market Size by Type
4.1 Global Histone Deacetylase (HDAC) Inhibitor Historic Market Review by Type (2015-2020)
4.1.1 Global Histone Deacetylase (HDAC) Inhibitor Sales Market Share by Type (2015-2020)
4.1.2 Global Histone Deacetylase (HDAC) Inhibitor Revenue Market Share by Type (2015-2020)
4.1.3 Global Histone Deacetylase (HDAC) Inhibitor Price by Type (2014-2020)
4.2 Global Histone Deacetylase (HDAC) Inhibitor Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Histone Deacetylase (HDAC) Inhibitor Sales Forecast by Type (2021-2026)
4.2.2 Global Histone Deacetylase (HDAC) Inhibitor Revenue Forecast by Type (2021-2026)
4.2.3 Global Histone Deacetylase (HDAC) Inhibitor Price Forecast by Type (2021-2026)
5 Global Histone Deacetylase (HDAC) Inhibitor Market Size by Application
5.1 Global Histone Deacetylase (HDAC) Inhibitor Historic Market Review by Application (2015-2020)
5.1.1 Global Histone Deacetylase (HDAC) Inhibitor Sales Market Share by Application (2015-2020)
5.1.2 Global Histone Deacetylase (HDAC) Inhibitor Revenue Market Share by Application (2015-2020)
5.1.3 Global Histone Deacetylase (HDAC) Inhibitor Price by Application (2015-2020)
5.2 Global Histone Deacetylase (HDAC) Inhibitor Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Histone Deacetylase (HDAC) Inhibitor Sales Forecast by Application (2021-2026)
5.2.2 Global Histone Deacetylase (HDAC) Inhibitor Revenue Forecast by Application (2021-2026)
5.2.3 Global Histone Deacetylase (HDAC) Inhibitor Price Forecast by Application (2021-2026)
3 North America Histone Deacetylase (HDAC) Inhibitor Market Facts & Figures
3.2 North America Histone Deacetylase (HDAC) Inhibitor Sales Market Share by Company (2015-2020)
3.3 North America Histone Deacetylase (HDAC) Inhibitor Sales Market Share by Type (2015-2020)
3.4 North America Histone Deacetylase (HDAC) Inhibitor Sales Market Share by Application (2015-2020)
4 Europe Histone Deacetylase (HDAC) Inhibitor Market Facts & Figures
4.2 Europe Histone Deacetylase (HDAC) Inhibitor Sales Market Share by Company (2015-2020)
4.3 Europe Histone Deacetylase (HDAC) Inhibitor Sales Market Share by Type (2015-2020)
4.4 Europe Histone Deacetylase (HDAC) Inhibitor Sales Market Share by Application (2015-2020)
5 China Histone Deacetylase (HDAC) Inhibitor Market Facts & Figures
5.2 China Histone Deacetylase (HDAC) Inhibitor Sales Market Share by Company (2015-2020)
5.3 China Histone Deacetylase (HDAC) Inhibitor Sales Market Share by Type (2015-2020)
5.4 China Histone Deacetylase (HDAC) Inhibitor Sales Market Share by Application (2015-2020)
6 Japan Histone Deacetylase (HDAC) Inhibitor Market Facts & Figures
6.2 Japan Histone Deacetylase (HDAC) Inhibitor Sales Market Share by Company (2015-2020)
6.3 Japan Histone Deacetylase (HDAC) Inhibitor Sales Market Share by Type (2015-2020)
6.4 Japan Histone Deacetylase (HDAC) Inhibitor Sales Market Share by Application (2015-2020)
7 Southeast Asia Histone Deacetylase (HDAC) Inhibitor Market Facts & Figures
7.2 Southeast Asia Histone Deacetylase (HDAC) Inhibitor Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Histone Deacetylase (HDAC) Inhibitor Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Histone Deacetylase (HDAC) Inhibitor Sales Market Share by Application (2015-2020)
8 India Histone Deacetylase (HDAC) Inhibitor Market Facts & Figures
8.2 India Histone Deacetylase (HDAC) Inhibitor Sales Market Share by Company (2015-2020)
8.3 India Histone Deacetylase (HDAC) Inhibitor Sales Market Share by Type (2015-2020)
8.4 India Histone Deacetylase (HDAC) Inhibitor Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Histone Deacetylase (HDAC) Inhibitor Business
12.1 Celgene
12.1.1 Celgene Histone Deacetylase (HDAC) Inhibitor Corporation Information
12.1.2 Celgene Histone Deacetylase (HDAC) Inhibitor Business Overview and Total Revenue
12.1.3 Celgene Histone Deacetylase (HDAC) Inhibitor Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Celgene Histone Deacetylase (HDAC) Inhibitor Products Offered
12.1.5 Celgene Recent Development
12.2 Celleron Therapeutics
12.2.1 Celleron Therapeutics Histone Deacetylase (HDAC) Inhibitor Corporation Information
12.2.2 Celleron Therapeutics Histone Deacetylase (HDAC) Inhibitor Business Overview and Total Revenue
12.2.3 Celleron Therapeutics Histone Deacetylase (HDAC) Inhibitor Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Celleron Therapeutics Histone Deacetylase (HDAC) Inhibitor Products Offered
12.2.5 Celleron Therapeutics Recent Development
12.3 CrystalGenomics
12.3.1 CrystalGenomics Histone Deacetylase (HDAC) Inhibitor Corporation Information
12.3.2 CrystalGenomics Histone Deacetylase (HDAC) Inhibitor Business Overview and Total Revenue
12.3.3 CrystalGenomics Histone Deacetylase (HDAC) Inhibitor Sales, Revenue and Gross Margin (2015-2020)
12.3.4 CrystalGenomics Histone Deacetylase (HDAC) Inhibitor Products Offered
12.3.5 CrystalGenomics Recent Development
12.4 Acetylon Pharmaceuticals
12.4.1 Acetylon Pharmaceuticals Histone Deacetylase (HDAC) Inhibitor Corporation Information
12.4.2 Acetylon Pharmaceuticals Histone Deacetylase (HDAC) Inhibitor Business Overview and Total Revenue
12.4.3 Acetylon Pharmaceuticals Histone Deacetylase (HDAC) Inhibitor Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Acetylon Pharmaceuticals Histone Deacetylase (HDAC) Inhibitor Products Offered
12.4.5 Acetylon Pharmaceuticals Recent Development
12.5 Novartis
12.5.1 Novartis Histone Deacetylase (HDAC) Inhibitor Corporation Information
12.5.2 Novartis Histone Deacetylase (HDAC) Inhibitor Business Overview and Total Revenue
12.5.3 Novartis Histone Deacetylase (HDAC) Inhibitor Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Novartis Histone Deacetylase (HDAC) Inhibitor Products Offered
12.5.5 Novartis Recent Development
12.6 Envivo Pharmaceuticals
12.6.1 Envivo Pharmaceuticals Histone Deacetylase (HDAC) Inhibitor Corporation Information
12.6.2 Envivo Pharmaceuticals Histone Deacetylase (HDAC) Inhibitor Business Overview and Total Revenue
12.6.3 Envivo Pharmaceuticals Histone Deacetylase (HDAC) Inhibitor Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Envivo Pharmaceuticals Histone Deacetylase (HDAC) Inhibitor Products Offered
12.6.5 Envivo Pharmaceuticals Recent Development
…
13 Histone Deacetylase (HDAC) Inhibitor Manufacturing Cost Analysis
13.1 Histone Deacetylase (HDAC) Inhibitor Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Histone Deacetylase (HDAC) Inhibitor
13.4 Histone Deacetylase (HDAC) Inhibitor Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Histone Deacetylase (HDAC) Inhibitor Distributors List
14.3 Histone Deacetylase (HDAC) Inhibitor Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Histone Deacetylase (HDAC) Inhibitor Sales (K Pcs) Growth Rate by Type (2020-2026)
Table 2. Global Histone Deacetylase (HDAC) Inhibitor Sales (K Pcs) Comparison by Application (2020-2026)
Table 3. Global Market Histone Deacetylase (HDAC) Inhibitor Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Histone Deacetylase (HDAC) Inhibitor Sales (K Pcs) by Region (2015-2020)
Table 5. Global Histone Deacetylase (HDAC) Inhibitor Sales Market Share by Region (2015-2020)
Table 6. Global Histone Deacetylase (HDAC) Inhibitor Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Histone Deacetylase (HDAC) Inhibitor Revenue Share by Region (2015-2020)
Table 8. Global Histone Deacetylase (HDAC) Inhibitor Sales (K Pcs) Forecast by Region (2021-2026)
Table 9. Global Histone Deacetylase (HDAC) Inhibitor Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Histone Deacetylase (HDAC) Inhibitor Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Histone Deacetylase (HDAC) Inhibitor Revenue Share Forecast by Region (2021-2026)
Table 12. Global Histone Deacetylase (HDAC) Inhibitor (K Pcs) of Key Companies (2015-2020)
Table 13. Global Histone Deacetylase (HDAC) Inhibitor Sales Share by Company (2015-2020)
Table 14. Global Histone Deacetylase (HDAC) Inhibitor Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Histone Deacetylase (HDAC) Inhibitor Revenue Share by Company (2015-2020)
Table 16. Global Histone Deacetylase (HDAC) Inhibitor by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Histone Deacetylase (HDAC) Inhibitor as of 2019)
Table 17. Global Histone Deacetylase (HDAC) Inhibitor Average Price (USD/Pcs) of Key Company (2015-2020)
Table 18. Manufacturers Histone Deacetylase (HDAC) Inhibitor Manufacturing Sites and Area Served
Table 19. Manufacturers Histone Deacetylase (HDAC) Inhibitor Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Histone Deacetylase (HDAC) Inhibitor Players
Table 22. Global Histone Deacetylase (HDAC) Inhibitor Sales (K Pcs) by Type (2015-2020)
Table 23. Global Histone Deacetylase (HDAC) Inhibitor Sales Share by Type (2015-2020)
Table 24. Global Histone Deacetylase (HDAC) Inhibitor Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Histone Deacetylase (HDAC) Inhibitor Price (K Pcs) by Type (2015-2020)
Table 26. Global Histone Deacetylase (HDAC) Inhibitor Sales Share by Type (2021-2026)
Table 27. Global Histone Deacetylase (HDAC) Inhibitor Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Histone Deacetylase (HDAC) Inhibitor Revenue Share by Type (2021-2026)
Table 29. Global Histone Deacetylase (HDAC) Inhibitor Price (K Pcs) by Type (2021-2026)
Table 30. Global Histone Deacetylase (HDAC) Inhibitor Sales (K Pcs) by Application (2015-2020)
Table 31. Global Histone Deacetylase (HDAC) Inhibitor Sales Share by Application (2015-2020)
Table 32. Global Histone Deacetylase (HDAC) Inhibitor Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Histone Deacetylase (HDAC) Inhibitor Price (K Pcs) by Application (2015-2020)
Table 34. Global Histone Deacetylase (HDAC) Inhibitor Sales (K Pcs) by Application (2021-2026)
Table 35. Global Histone Deacetylase (HDAC) Inhibitor Sales Share by Application (2021-2026)
Table 36. Global Histone Deacetylase (HDAC) Inhibitor Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Histone Deacetylase (HDAC) Inhibitor Revenue Share by Application (2021-2026)
Table 38. Global Histone Deacetylase (HDAC) Inhibitor Price (K Pcs) by Application (2021-2026)
Table 39. United States Histone Deacetylase (HDAC) Inhibitor Sales (K Pcs) by Company (2015-2020)
Table 40. United States Histone Deacetylase (HDAC) Inhibitor Sales Market Share by Company (2015-2020)
Table 41. United States Histone Deacetylase (HDAC) Inhibitor Sales (K Pcs) by Type (2015-2020)
Table 42. United States Histone Deacetylase (HDAC) Inhibitor Sales Market Share by Type (2015-2020)
Table 43. United States Histone Deacetylase (HDAC) Inhibitor Sales (K Pcs) by Application (2015-2020)
Table 44. United States Histone Deacetylase (HDAC) Inhibitor Sales Market Share by Application (2015-2020)
Table 45. Europe Histone Deacetylase (HDAC) Inhibitor Sales (K Pcs) by Company (2015-2020)
Table 46. Europe Histone Deacetylase (HDAC) Inhibitor Sales Market Share by Company (2015-2020)
Table 47. Europe Histone Deacetylase (HDAC) Inhibitor Sales (K Pcs) by Type (2015-2020)
Table 48. Europe Histone Deacetylase (HDAC) Inhibitor Sales Market Share by Type (2015-2020)
Table 49. Europe Histone Deacetylase (HDAC) Inhibitor Sales (K Pcs) by Application (2015-2020)
Table 50. Europe Histone Deacetylase (HDAC) Inhibitor Sales Market Share by Type (2015-2020)
Table 51. China Histone Deacetylase (HDAC) Inhibitor Sales (K Pcs) by Company (2015-2020)
Table 52. China Histone Deacetylase (HDAC) Inhibitor Sales Market Share by Company (2015-2020)
Table 53. China Histone Deacetylase (HDAC) Inhibitor Sales (K Pcs) by Type (2015-2020)
Table 54. China Histone Deacetylase (HDAC) Inhibitor Sales Market Share by Type (2015-2020)
Table 55. China Histone Deacetylase (HDAC) Inhibitor Sales (K Pcs) by Application (2015-2020)
Table 56. China Histone Deacetylase (HDAC) Inhibitor Sales Market Share by Application (2015-2020)
Table 57. Japan Histone Deacetylase (HDAC) Inhibitor Sales (K Pcs) by Company (2015-2020)
Table 58. Japan Histone Deacetylase (HDAC) Inhibitor Sales Market Share by Company (2015-2020)
Table 59. Japan Histone Deacetylase (HDAC) Inhibitor Sales (K Pcs) by Type (2015-2020)
Table 60. Japan Histone Deacetylase (HDAC) Inhibitor Sales Market Share by Type (2015-2020)
Table 61. Japan Histone Deacetylase (HDAC) Inhibitor Sales (K Pcs) by Application (2015-2020)
Table 62. Japan Histone Deacetylase (HDAC) Inhibitor Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Histone Deacetylase (HDAC) Inhibitor Sales (K Pcs) by Company (2015-2020)
Table 64. Southeast Asia Histone Deacetylase (HDAC) Inhibitor Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Histone Deacetylase (HDAC) Inhibitor Sales (K Pcs) by Type (2015-2020)
Table 66. Southeast Asia Histone Deacetylase (HDAC) Inhibitor Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Histone Deacetylase (HDAC) Inhibitor Sales (K Pcs) by Type (2015-2020)
Table 68. Southeast Asia Histone Deacetylase (HDAC) Inhibitor Sales Market Share by Application (2015-2020)
Table 69. India Histone Deacetylase (HDAC) Inhibitor Sales (K Pcs) by Company (2015-2020)
Table 70. India Histone Deacetylase (HDAC) Inhibitor Sales Market Share by Company (2015-2020)
Table 71. India Histone Deacetylase (HDAC) Inhibitor Sales (K Pcs) by Type (2015-2020)
Table 72. India Histone Deacetylase (HDAC) Inhibitor Sales Market Share by Type (2015-2020)
Table 73. India Histone Deacetylase (HDAC) Inhibitor Sales (K Pcs) by Application (2015-2020)
Table 74. India Histone Deacetylase (HDAC) Inhibitor Sales Market Share by Application (2015-2020)
Table 75. Celgene Corporation Information
Table 76. Celgene Description and Business Overview
Table 77. Celgene Histone Deacetylase (HDAC) Inhibitor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 78. Celgene Histone Deacetylase (HDAC) Inhibitor Product
Table 79. Celgene Recent Development
Table 80. Celleron Therapeutics Corporation Information
Table 81. Celleron Therapeutics Description and Business Overview
Table 82. Celleron Therapeutics Histone Deacetylase (HDAC) Inhibitor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 83. Celleron Therapeutics Histone Deacetylase (HDAC) Inhibitor Product
Table 84. Celleron Therapeutics Recent Development
Table 85. CrystalGenomics Corporation Information
Table 86. CrystalGenomics Description and Business Overview
Table 87. CrystalGenomics Histone Deacetylase (HDAC) Inhibitor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 88. CrystalGenomics Histone Deacetylase (HDAC) Inhibitor Product
Table 89. CrystalGenomics Recent Development
Table 90. Acetylon Pharmaceuticals Corporation Information
Table 91. Acetylon Pharmaceuticals Description and Business Overview
Table 92. Acetylon Pharmaceuticals Histone Deacetylase (HDAC) Inhibitor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 93. Acetylon Pharmaceuticals Histone Deacetylase (HDAC) Inhibitor Product
Table 94. Acetylon Pharmaceuticals Recent Development
Table 95. Novartis Corporation Information
Table 96. Novartis Description and Business Overview
Table 97. Novartis Histone Deacetylase (HDAC) Inhibitor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 98. Novartis Histone Deacetylase (HDAC) Inhibitor Product
Table 99. Novartis Recent Development
Table 100. Envivo Pharmaceuticals Corporation Information
Table 101. Envivo Pharmaceuticals Description and Business Overview
Table 102. Envivo Pharmaceuticals Histone Deacetylase (HDAC) Inhibitor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 103. Envivo Pharmaceuticals Histone Deacetylase (HDAC) Inhibitor Product
Table 104. Envivo Pharmaceuticals Recent Development
Table 105. Production Base and Market Concentration Rate of Raw Material
Table 106. Key Suppliers of Raw Materials
Table 107. Histone Deacetylase (HDAC) Inhibitor Distributors List
Table 108. Histone Deacetylase (HDAC) Inhibitor Customers List
Table 109. Market Key Trends
Table 110. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 111. Key Challenges
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Histone Deacetylase (HDAC) Inhibitor Product Picture
Figure 2. Global Histone Deacetylase (HDAC) Inhibitor Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Histone Deacetylase (HDAC) Inhibitor Market Share by Application in 2020 & 2026
Figure 6. Cancer Examples
Figure 7. Central Nervous System Disorders Examples
Figure 8. Other Diseases Examples
Figure 9. Global Histone Deacetylase (HDAC) Inhibitor Sales (K Pcs) Growth Rate (2015-2026)
Figure 10. Global Histone Deacetylase (HDAC) Inhibitor Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Histone Deacetylase (HDAC) Inhibitor Price Trends Growth Rate (2015-2026) (USD/Pcs)
Figure 12. Global Histone Deacetylase (HDAC) Inhibitor Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Histone Deacetylase (HDAC) Inhibitor Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Histone Deacetylase (HDAC) Inhibitor Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Histone Deacetylase (HDAC) Inhibitor Sales (K Pcs) Growth Rate (2015-2026)
Figure 16. Europe Histone Deacetylase (HDAC) Inhibitor Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Histone Deacetylase (HDAC) Inhibitor Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Histone Deacetylase (HDAC) Inhibitor Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Histone Deacetylase (HDAC) Inhibitor Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Histone Deacetylase (HDAC) Inhibitor Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Histone Deacetylase (HDAC) Inhibitor Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Histone Deacetylase (HDAC) Inhibitor Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Histone Deacetylase (HDAC) Inhibitor Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Histone Deacetylase (HDAC) Inhibitor Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Histone Deacetylase (HDAC) Inhibitor Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Histone Deacetylase (HDAC) Inhibitor Players Market Share by Revenue in Histone Deacetylase (HDAC) Inhibitor 2015 & 2019
Figure 27. Histone Deacetylase (HDAC) Inhibitor Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Histone Deacetylase (HDAC) Inhibitor Revenue Share by Type (2015-2020)
Figure 29. Global Histone Deacetylase (HDAC) Inhibitor Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Histone Deacetylase (HDAC) Inhibitor Revenue Share by Application (2015-2020)
Figure 31. Global Histone Deacetylase (HDAC) Inhibitor Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Histone Deacetylase (HDAC) Inhibitor Sales Market Share by Type in 2019
Figure 33. United States Histone Deacetylase (HDAC) Inhibitor Sales Market Share by Type in 2019
Figure 34. Europe Histone Deacetylase (HDAC) Inhibitor Sales Market Share by Company in 2019
Figure 35. Europe Histone Deacetylase (HDAC) Inhibitor Sales Market Share by Type in 2019
Figure 36. Europe Histone Deacetylase (HDAC) Inhibitor Sales Market Share by Application in 2019
Figure 37. China Histone Deacetylase (HDAC) Inhibitor Sales Market Share by Company in 2019
Figure 38. China Histone Deacetylase (HDAC) Inhibitor Sales Market Share by Type in 2019
Figure 39. China Histone Deacetylase (HDAC) Inhibitor Sales Market Share by Application in 2019
Figure 40. Japan Histone Deacetylase (HDAC) Inhibitor Sales Market Share by Company in 2019
Figure 41. Japan Histone Deacetylase (HDAC) Inhibitor Sales Market Share by Type in 2019
Figure 42. Japan Histone Deacetylase (HDAC) Inhibitor Sales Market Share by Application in 2019
Figure 43. Southeast Asia Histone Deacetylase (HDAC) Inhibitor Sales Market Share by Company in 2019
Figure 44. Southeast Asia Histone Deacetylase (HDAC) Inhibitor Sales Market Share by Type in 2019
Figure 45. Southeast Asia Histone Deacetylase (HDAC) Inhibitor Sales Market Share by Application in 2019
Figure 46. India Histone Deacetylase (HDAC) Inhibitor Sales Market Share by Company in 2019
Figure 47. India Histone Deacetylase (HDAC) Inhibitor Sales Market Share by Type in 2019
Figure 48. India Histone Deacetylase (HDAC) Inhibitor Sales Market Share by Application in 2019
Figure 49. Celgene Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Celleron Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. CrystalGenomics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Acetylon Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Envivo Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Key Raw Materials Price Trend
Figure 56. Manufacturing Cost Structure of Histone Deacetylase (HDAC) Inhibitor
Figure 57. Manufacturing Process Analysis of Histone Deacetylase (HDAC) Inhibitor
Figure 58. Histone Deacetylase (HDAC) Inhibitor Industrial Chain Analysis
Figure 59. Channels of Distribution
Figure 60. Distributors Profiles
Figure 61. Porter's Five Forces Analysis
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
ヒストンデアセチラーゼ（HDAC）阻害剤の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Histone Deacetylase (HDAC) Inhibitor market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Histone …- 多発性骨髄腫治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Multiple Myeloma Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 10.2% in the forecast period of 2020 to 2025 and will expected to reach USD 41350 million by 2025, from USD 28060 million in 2019. The Multiple M…
- サイトカイン阻害剤の世界市場レポート2020 Market Analysis and Insights: Global Cytokine Inhibitor Market The global Cytokine Inhibitor market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Cytokine Inhibitor Scope and Market Size The global Cytokine In…
- B細胞阻害剤の世界市場レポート2020 Market Analysis and Insights: Global B-Cell Inhibitor Market The global B-Cell Inhibitor market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global B-Cell Inhibitor Scope and Market Size The global B-Cell Inhibitor …
- イミダゾリン誘導体阻害剤の世界市場レポート2020 Market Analysis and Insights: Global Imidazoline Derivative Inhibitor Market The global Imidazoline Derivative Inhibitor market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Imidazoline Derivative Inhibitor Sc…